Sep 10, 2018

I've actually been in contact with Doug Clinton for many months but only now have done an episode. He is a managing partner at Loup Ventures which has recently invested money in companies such as Neurable and former guest Paradromics. In this episode, we talk about why their firm invests in companies which have a longer time horizon like medical device companies rather than software companies like in Silicon Valley. He talks about what he looks for in a company when investing and why their companies don't worry about FDA approval and even see it as a benefit.

Doug is also the host of the Neurotech Podcast which covers many similar things in the field of Neural Implants but with a eye more towards the investment side of things.